Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats

✍ Scribed by Lu Luo; De-Zai Dai; Yu-Si Cheng; Qi Zhang; Wen-Jun Yuan; Yin Dai

• Book ID: 118111511
• Publisher: Pharmaceutical Press
• Year: 2011
• Tongue: English
• Weight: 967 KB
• Volume: 63
• Category: Article
• ISSN: 2042-7158
• DOI: 10.1111/j.2042-7158.2011.01268.x